About Sentiss Pharma
Sentiss Pharma is a company based in Gurugram (India) founded in 1990 by Deepak Bahri. It operates as a B2B and Contract Manufacturing. The company has 689 employees. Sentiss Pharma offers products and services including Ophthalmic Products, Inhalational Products, ENT Products, and Specialty Products. Sentiss Pharma operates in a competitive market with competitors including Annexon, Aldeyra, Lyra Therapeutics, Nicox and Decibel Therapeutics, among others.
- Headquarter Gurugram, India
- Employees 689
- Founders Deepak Bahri
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website sentisspharma.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Sentiss Pharma Private Limited
- Date of Incorporation 13 Jan, 1994
- Jurisdiction Delhi, India
- Annual Revenue₹1,263 Cr
FY 2025 · +43% YoY
- Net Profit₹35.79 Cr
FY 2025 · 3% margin
- EBITDA₹214 Cr
FY 2025 · 17% margin
- Employee Count689
Associated legal entities of Sentiss Pharma
Sentiss Pharma operates through Sentiss Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sentiss Pharma Private Limited CIN U74899DL1994PTC056894 | Active | 13 Jan 1994 | New Delhi, Delhi | ₹1,263 Cr | 689 | 6 | View details |
Products & Services of Sentiss Pharma
Sentiss Pharma offers a comprehensive portfolio of products and services, including Ophthalmic Products, Inhalational Products, ENT Products, and Specialty Products.
Treats eye conditions with quality pharmaceutical solutions
Delivers medications for nebulization and breathing therapies
Provides treatments for ear, nose, and throat ailments
Offers innovative solutions for various medical specialties
Apps and channels of Sentiss Pharma
its YouTube channel Sentiss Pharma Pvt. Ltd. has 414 subscribers and 8 videos.
Videos from Sentiss Pharma
The most watched videos on Sentiss Pharma's YouTube channel, Sentiss Pharma Pvt. Ltd. (414 subscribers). Click a video to play it here.
More on Sentiss Pharma Pvt. Ltd..
Board of directors of Sentiss Pharma Private Limited (Sentiss Pharma)
Sentiss Pharma Private Limited is the primary company behind Sentiss Pharma. The board of Sentiss Pharma Private Limited currently have 6 directors; the longest-serving is Deepak Bahri, appointed in 1995. 15 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Deepak Bahri DIN 00358757 | Managing Director | 01 May 1995 | 31 yrs 5 mo | Sentiss Pharma Private Limited |
| Mahesh Kumar Garg DIN 07206416 | Director | 09 Jun 2015 | 11 yrs 4 mo | Sentiss Pharma Private Limited |
| Geeta Mathur DIN 02139552 | Director | 17 Jul 2017 | 9 yrs 2 mo | Sentiss Pharma Private Limited |
| Canakapalli Bhaktavatasala Rao DIN 00010175 | Director | 29 Apr 2019 | 7 yrs 5 mo | Sentiss Pharma Private Limited |
| Deepak Kumar Khungar DIN 10838126 | Director | 21 Nov 2024 | 1 yr 10 mo | Sentiss Pharma Private Limited |
| Sameer Agarwal DIN 10937820 | Director | 10 Feb 2025 | 1 yr 7 mo | Sentiss Pharma Private Limited |
People of Sentiss Pharma
17 people are tracked at Sentiss Pharma (5 in leadership, 12 in team); the tracked headcount is 689.
| Name | Role | Group |
|---|---|---|
| Founder, CEO | Leadership | |
Nimish Jindal | Chief Financial Officer | Leadership |
Ranjeet Singh | Deaputy General Manager QA | Leadership |
Esha Sharma | Head Of Marketing | Leadership |
Sonia Sawhney | Head Of Talent Acquisition | Leadership |
Divyansh Jindal | Senior Finance Executive | Team |
Ankita Sharma | Sr. Executive | Team |
Ajay Dobhal | Senior Manager - QA | Team |
Manish Jain | Manager | Team |
Manoj Nahar | DGM | Team |
Yana Belenkaia | Lead Product Manager | Team |
Ishwar Dev | Executive | Team |
Vibhor Sharma | DGM | Team |
Rewa Thakur | Executive | Team |
Alok Bahri | Manager Commercial Strategy | Team |
Vikas Pandita | Manager Quality Control Stability Sentiss Pharma Pvt | Team |
Pallab Basu | Divisional Sales Manager East & South India Business | Team |
Complete people profiles for Sentiss Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Sentiss Pharma
Figures of Sentiss Pharma Private Limited, the primary company behind Sentiss Pharma, for FY 2025. Revenue was ₹1,263 Cr (+43% year on year). Net profit was ₹35.79 Cr (3% margin). EBITDA was ₹214 Cr (17% margin). Revenue has grown at a compounded annual rate of +43% over three years and +24% over five years.
- ₹1,263 CrRevenue · FY 2025 · +43% YoY
- ₹35.79 CrNet profit · 3% margin
- ₹214 CrEBITDA · 17% margin
- ₹5.88 CrPaid-up capital
- 689Employees (provident fund records)
- +43%Revenue CAGR, 3 years
- +24%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sentiss Pharma Private Limited are on its company page.
Detailed financial statements for Sentiss Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Sentiss Pharma
Sentiss Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Annexon, Aldeyra, Lyra Therapeutics, Nicox and Decibel Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| annexonbio.com | 2011 | San Francisco, United States | $256M | 80 | Developer of antibodies to treat complement-mediated neurodegenerative diseases | |
| aldeyra.com | 2004 | Lexington, United States | $4.79M | 30 | Drug candidates for immune-mediated diseases are developed by Aldeyra. | |
| lyratherapeutics.com | 2005 | Watertown, United States | $127.61M | 75 | Small molecule therapeutics for ENT diseases are developed. | |
| nicox.com | 1996 | Valbonne, France | $271.01M | – | Nitric oxide-based therapeutics for glaucoma and eye conditions are developed. | |
| decibeltx.com | 2015 | Cambridge, United States | $169.53M | 62 | Medicines are developed to protect, repair, and restore hearing capacity. | |
| gyroscope.cc | 2016 | San Francisco, United States | – | – | Mobile SDK developed for app engagement and monetization strategies. | |
| meiragtx.com | 2015 | New York, United States | – | 358 | Gene therapies for ocular and neurodegenerative diseases are developed. | |
| gensight-biologics.com | 2011 | Paris, France | $76.63M | – | Viral vector-based gene therapies for retinal diseases are developed. | |
| kriyatherapeutics.com | 2012 | Redwood, United States | $930.93M | 159 | Developer of therapeutic solutions for the treatment of diabetes | |
| alimerasciences.com | 2003 | Alpharetta, United States | $66.8M | 79 | Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized. |
Detailed competitors of Sentiss Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sentiss Pharma
The website of Sentiss Pharma (sentisspharma.com) receives about 10.3K visits a month and ranks #1,920,442 among all websites worldwide, #2,623 in Biotechnology and Pharmaceuticals.
- Monthly visits10.3K
▲ 35.8% vs previous month
- Unique visitors2.2K
per month
- Global rank#1,920,442
among all websites
- Category rank#2,623
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit5.7
- Average visit4 min 31 sec
- DevicesDesktop 54% · Mobile 46%
Websites whose visitors overlap most with Sentiss Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| synokempharma.com | 100% | 1.8K | #7,667,368 | View details | |
baxter.in | baxter.in | 92% | – | #1,654,418 | – |
| alcheminternational.com | 85% | 13.4K | #6,011,638 | View details | |
| belcoindia.com | 85% | – | #2,738,256 | View details | |
jpm.com.jo | jpm.com.jo | 84% | – | #6,722,301 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for Sentiss Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Sentiss Pharma
Complete news archive for Sentiss Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Sentiss Pharma
10 companies that operate in the same segment as Sentiss Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sentiss Pharma
Sentiss Pharma was founded in 1990.
Sentiss Pharma is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Deepak Bahri is the current CEO of Sentiss Pharma. They have also founded this company.
Sentiss Pharma has 689 employees.
The primary company behind Sentiss Pharma, Sentiss Pharma Private Limited, reported revenue of ₹1,263 Cr for FY 2025, up 43% year on year.
Sentiss Pharma is a pharmaceutical company established in 1990, focusing on creating value through generic and innovative eye care, inhalational, ENT, and specialty products. It operates primarily from India, with offices in Gurgaon and manufacturing in Himachal Pradesh, while serving global customers via affiliates. The company emphasizes research, development, quality manufacturing, and social initiatives in health and education.
Sentiss Pharma's top competitors include Annexon, Decibel Therapeutics and Alimera Sciences.
Sentiss Pharma offers Ophthalmic Products, Inhalational Products, ENT Products, and Specialty Products.
Sentiss Pharma operates through Sentiss Pharma Private Limited.
The legal entities of Sentiss Pharma currently have 6 directors, including Canakapalli Bhaktavatasala Rao, Deepak Bahri, Mahesh Kumar Garg and others.